ANNA BIOSCIENCES

WIPO WIPO 2021

Protect this trademark from copycats!

With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.

The International trademark ANNA BIOSCIENCES was filed as Word mark on 04/06/2021 at the World Intellectual Property Organization.

Trademark Details Last update: May 25, 2023

Trademark form Word mark
File reference 1660856
Countries Australia Canada China European Community United Kingdom India Japan
Base trademark US No. 90621293, April 2, 2021
Application date April 6, 2021
Expiration date April 6, 2031

Trademark owner

12 Merrion Square
Dublin 2
IE

Trademark representatives

1000 TOWN CENTER, 22ND FLOOR SOUTHFIELD MI 48075 US

goods and services

05 Biological, medicinal and pharmaceutical preparations, namely, therapeutics for the treatment of infertility, genetic, viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, neuromuscular, rare muscle diseases, cardiomyopathies, heart muscle diseases, muscular dystrophies, muscle atrophy, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; diagnostic preparations for medical and clinical laboratory use; dietetic preparations, namely, nutritional supplements based on vitamins, minerals and probiotics; chemicals for use in medical laboratories, namely, diagnostic chemicals
41 Computer services, namely, providing educational information about chemicals, pharmaceuticals, diagnostic and laboratory products as well as biochemical, biological, chemical, immunochemical and immunological compositions and preparations provided through a website and distributed via global computer network
42 Product development for others relating to pharmaceuticals, biopharmaceuticals, health care products and medical products; scientific and technological consulting services in the pharmaceutical industry, and research and design relating thereto; industrial analysis in the nature of product testing and research and industrial research in the field of pharmaceuticals, biopharmaceuticals, health care products and medical products; pharmaceutical and biopharmaceutical drug development services; pharmaceutical and biopharmaceutical research and development; product development consultation; product research services, namely, providing analytical testing, biosafety testing, reporting and laboratory services for others; scientific and technical product development consulting and research services for the pharmaceutical industry; custom design and development of chemical reagents and biochemical assays; research and development services in the field of cancer immunotherapy; conducting clinical trials for others in the field of cancer immunotherapy; scientific and industrial research; planning and executing projects in the area of the supply of pharmaceuticals, namely, development of pharmaceutical substances, providing know-how, information and consulting services in high throughput screening of chemicals during chemical analysis, chemical synthesis, toxicological and pharmaceutical research, genome target identification and validation, consulting services in production and development in the field of pharmaceuticals, biopharmaceuticals, health care products and medical products, animal and human pharmacokinetic evaluations, consulting services by providing clinical development concepts; providing on-line computer databases featuring medical terminology, medical and pharmaceutical data and scientific, medical and pharmaceutical counseling information (term considered too vague by the International Bureau - Rule 13 (2) (b) of the Regulations); drawing up scientific expert reports, documents and information; planning, performing and evaluating scientific studies; counseling with regard to ensuring drug safety and services, namely, providing respective information to patients, doctors and clients (term considered too vague by the International Bureau - Rule 13 (2) (b) of the Regulations); services rendered in the laboratory and chemical area, namely, development of analytical methods and drug master files, reviewing standards and practices to assure compliance with pharmaceutical application and regulation requirements and consultation in the area of upscaling of laboratory processes (term considered too vague by the International Bureau - Rule 13 (2) (b) of the Regulations); services relating to pharmaceutical preparations, namely, medical research, namely, providing information in printed form and via electronic means in the fields of oncology, metabolic and cardiovascular diseases or disorders, and diseases and disorders of the central nervous system (term considered too vague by the International Bureau - Rule 13 (2) (b) of the Regulations)
44 Providing information and counseling in healthcare; drawing up medical and pharmaceutical expert reports, documents and information; consulting services rendered in the medical, pharmaceutical, and pharma-economy sector; services relating to pharmaceutical preparations, namely, healthcare and medical advice, disease management, patient support services, namely, providing information in printed form and via electronic means in the fields of oncology, metabolic and cardiovascular diseases or disorders, and diseases and disorders of the central nervous system

Trademark history

Date Document number Area Entry
February 23, 2023 2023/8 Gaz JP Rejection
October 26, 2022 2022/43 Gaz CN Rejection
September 29, 2022 2022/39 Gaz EM Rejection
August 11, 2022 2022/32 Gaz GB Rejection
June 6, 2022 2022/23 Gaz IN Rejection
May 17, 2022 2022/21 Gaz AU Rejection
April 6, 2021 2022/17 Gaz US Registration

ID: 141660856